INFORMATIONAL PURPOSES ONLY. Not medical, legal, or travel advice. Verify with official sources before acting. See corrections log.

Medical Freedom Maps

Home » Maps » Regenerative medicine » Nebraska

Regenerative medicine in Nebraska

Regenerative medicine laws and requirements in Nebraska. Citations, verification dates, and source links for every data point.

DimensionValueCitationSourceVerifiedConfidence
Permit Unapproved Cell Therapiesdo not explicitly permit sources differNeb. Rev. Stat. § 38-1,147 (Laws 2022, LB752, § 6)“shall, by informed written consent, communicate to any patient seeking stem-cell-based therapy”Note: Coordinator override: Nebraska has a disclosure/awareness statute (LB 752, 2022) regulating practitioners who perform non-FDA-approved stem-cell-based therapy, but it does not expressly authorize such therapy (same treatment as WA/VT). The 2024 Cytotherapy review used by the sub-check omitted Nebraska.Link2026-10-09medium
Require Patient Disclosure for Cell Therapiesrequire disclosureNeb. Rev. Stat. § 38-1,147 (Laws 2022, LB752, § 6)“shall, by informed written consent, communicate to any patient seeking stem-cell-based therapy”Note: Coordinator override: statute requires informed written consent communicating that the therapy is not FDA-approved; exempts FDA-approved products and IND/IDE therapies.Link2026-10-09high
Limit Practitioner Scope for Cell TherapiesNotice/consent duty applies to any health care practitioner licensed or certified under the Uniform Credentialing Act who performs stem-cell-based therapy; FDA-approved products and FDA IND/IDE therapies are exempt.Neb. Rev. Stat. § 38-1,147 (Laws 2022, LB752, § 6)“Health care practitioner means a person licensed or certified under the Uniform Credentialing Act.”Note: Coordinator override. Statute does not limit who may administer; it imposes a consent duty on credentialed practitioners.Link2026-10-09high
Have Cell Therapy Statute ReferencesNeb. Rev. Stat. § 38-1,147 (LB 752, 2022)Neb. Rev. Stat. § 38-1,147 (Laws 2022, LB752, § 6)“shall, by informed written consent, communicate to any patient seeking stem-cell-based therapy”Note: Coordinator override. Source note on official page: Laws 2022, LB752, § 6.Link2026-10-09high

View full Nebraska profile (all layers) · Report an error on this page

Methodology: every value was checked in October 2026 against a specific source (statute, regulator or official list, or a named tracker page), and each links to that page with a short quote. Values no source could support are shown as “Not verified”. Verification was AI-assisted and spot-checked; laws change, so confirm with the linked source before relying on a value. How values are verified · Report an error.